Executive Summary
Significant contract modifications totaling $1,236,299,978 from April 11, 2026, feature 1/3 defense-related obligations amid predominantly civilian IT and construction sectors. Dominant themes center on GSA and VA IT delivery orders, with Leidos ($543.6M) and Oracle Health Government Services ($519.0M) providing the highest materiality bullish signals for funded backlogs in mature multi-year contracts.
BL Harbert International's $173.7M State Department construction award adds neutral exposure to overseas projects. Highest-conviction signal is Oracle's $519M VA EHRM operations delivery order (materiality 8/10, strength 7/10), signaling stable VA IT demand. Key risk: $0 outlays on Oracle and BL Harbert contracts plus Leidos' negative $-1.7M outlay flag execution delays and uncertain revenue ramps.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Significant Contract Modifications ($10M+) digest from April 10, 2026.
Investment Signals (3)
- Leidos $543.6M GSA IT Delivery Order Modification (MEDIUM)▲
Leidos received a $543.6M total obligation (potential $729.6M with options) under cost-plus award fee for IT/telecom services via full and open competition, representing ~$83.6M annual revenue estimate over 6.5 years despite negative $-1.7M outlay.
- Oracle Health Government Services $519.0M VA EHRM Operations Modification (HIGH)▲
Oracle Health Government Services secured a $519.0M firm fixed price delivery order (potential $632.8M with options) for EHRM operations under non-competed award, equating to ~$104M annual estimate over 5 years with $0 outlay to date.
- BL Harbert International $173.7M State Department Construction Modification (LOW)▲
BL Harbert International awarded $173.7M firm fixed price definitive contract for Podgorica Montenegro project via full and open competition, ~$23.1M annual over 7.5 years with $0 outlay and $5.5M subawards across 47 recipients.
Risk Flags (3)
- Execution [MEDIUM RISK]▼
Leidos GSA contract shows negative $-1.7M total outlay despite $543.6M obligation, signaling potential spending halts or reimbursements on mature IT delivery order ending 2024-02-29.
- Execution [HIGH RISK]▼
$0 outlays on Oracle $519.0M VA EHRM and BL Harbert $173.7M State Department contracts indicate delayed funding ramps on firm fixed price structures.
- Budget [HIGH RISK]▼
High contract pricing risk (firm fixed price) on Oracle VA and BL Harbert State Department awards amid $0 outlays and long performance periods to 2027.
Opportunities (2)
- ◆
Leidos GSA IT order potential upside to $729.6M via remaining options on $543.6M obligation.
- ◆
Oracle VA EHRM delivery order expansion to $632.8M base + options from current $519.0M obligation.
Sector Themes (1)
- ◆
Leidos $543.6M GSA and Oracle $519.0M VA delivery orders (both NAICS 541512) represent $1.06B in IT/telecom obligations with extensive subawards ($187M Leidos, $12.5M Oracle), signaling robust funded backlogs despite low outlays.
Watch List (3)
- 👁
{"entity"=>"Leidos Holdings, Inc.", "reason"=>"$543.6M GSA obligation with negative $-1.7M outlay and $187.4M subawards across 1090 recipients on contract ending 2024-02-29.", "trigger"=>"total outlay progress; exercise of options to $729.6M"}
- 👁
{"entity"=>"Oracle Health Government Services, Inc.", "reason"=>"$519.0M VA EHRM with $0 outlay and 34 subawards totaling $12.5M on 5-year performance to 2027-04-10.", "trigger"=>"outlay progress from $0; exercise of options to $632.8M"}
- 👁
{"entity"=>"BL Harbert International LLC", "reason"=>"$173.7M State Department construction with $0 outlay and $5.5M subawards across 47 recipients to 2027-03-25.", "trigger"=>"outlay progress from $0; performance against end date"}
Get daily alerts with 3 investment signals, 3 risk alerts, 2 opportunities and full AI analysis of all 3 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Significant Contract Modifications ($10M+)
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals
May 27, 2026
Big Pharma Approvals — May 27, 2026
Big Pharma Approvals